UPC | NASDAQ

Universe Pharmaceuticals Inc

Universe Pharmaceuticals Inc (UPC) | runway 72.8 months | financing risk moderate | market cap $1.7M. Daily snapshot of financials, capital pressure, and rec...

Company websiteLast updated Apr 29, 2026

Share price

$3.23

As of Apr 29, 2026

Market cap

$1.7M

Snapshot valuation

30D volume

5,460 shares

Rolling average daily volume

Runway

72.8 months

Estimated from precomputed burn and cash

Financing risk

N/A

Financing risk is present, but the current picture is not yet acute.

Snapshot summary

Runway: 72.8 months based on estimated burn.

Financing signal: Financing risk is present, but the current picture is not yet acute.

Latest development: Universe Pharmaceuticals INC 6-K 2026-04-16.

Recent developments

Universe Pharmaceuticals INC 6-K 2026-04-16

6-K filed on 2026-04-16.

Apr 15, 2026, 8:00 PM

Universe Pharmaceuticals INC 6-K 2026-02-11

6-K filed on 2026-02-11.

Feb 10, 2026, 7:00 PM

Universe Pharmaceuticals INC 20-F 2026-01-29

20-F filed on 2026-01-29.

Jan 28, 2026, 7:00 PM

Universe Pharmaceuticals INC 6-K 2025-09-03

6-K filed on 2025-09-03.

Sep 2, 2025, 8:00 PM

Universe Pharmaceuticals INC 6-K 2025-08-26

6-K filed on 2025-08-26.

Aug 25, 2025, 8:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures